Chun Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 11
- Cancer, Hypoxia, and Metabolism 9
- Co-authors
- Ying XiongDuan‐Fang LiaoNing YuGabriel MbalavieleDixian LuoDeliang CaoYousef Abu‐AmerMingwei Sun
- Journals
- International Immunopharmacology (3 papers)Frontiers in Neurology (3 papers)BioMed Research International (3 papers)Frontiers in Oncology (3 papers)Digestive Diseases and Sciences (3 papers)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Chun Wang
94 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 354
- Pharmacology 119
- Complementary and alternative medicine 93
- Molecular Biology 774
- Immunology 216
Countries citing papers authored by Chun Wang
This map shows the geographic impact of Chun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Wang more than expected).
Fields of papers citing papers by Chun Wang
This network shows the impact of papers produced by Chun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Wang. The network helps show where Chun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 37 | |
| 8 | 2021 | 26 | |
| 9 | 2018 | 26 | |
| 10 | 2016 | 19 | |
| 11 | 2016 | 53 | |
| 12 | [Molecular Genetic Analysis of One Sudden Unexplained Death in the Young by Whole Exome Sequencing]. | 2015 | 1 |
| 13 | 2014 | 1 | |
| 14 | [Characteristics of 72 h glucose profiles detected by continuous glucose monitoring system in patients with insulinoma]. | 2014 | 2 |
| 15 | Pharmacokinetics of paeoniflorin microemulsion after repeated dosing in rats with adjuvant arthritis. | 2012 | 15 |
| 16 | 2012 | 1 | |
| 17 | 2010 | 17 | |
| 18 | 2009 | 89 | |
| 19 | miR-138 Function and Its Targets on Mouse Mammary Epithelial Cells | 2008 | 4 |
| 20 | Effects of anti--tumor drug harringtonine on the proliferation of HeLa cell and its relationship with {\sl CenpB} gene | 2005 | 1 |
About Chun Wang
Chun Wang is a scholar working on Cancer Research, Microbiology, Pharmacology, Epidemiology and Molecular Biology, having authored 95 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Autophagy in Disease and Therapy (7 papers), Circular RNAs in diseases (7 papers), Mitochondrial Function and Pathology (6 papers), Acute Ischemic Stroke Management (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). The work is most often cited by research in Cancer Research (354 citations), Pharmacology (119 citations), Complementary and alternative medicine (93 citations), Molecular Biology (774 citations) and Immunology (216 citations). Chun Wang has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Ying Xiong, Duan‐Fang Liao, Ning Yu, Gabriel Mbalaviele, Dixian Luo, Deliang Cao, Yousef Abu‐Amer, Mingwei Sun, Wei Wei and Chunying Liu. Their work appears in journals such as International Immunopharmacology, Frontiers in Neurology, BioMed Research International, Frontiers in Oncology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.